Acacia Research Corp
NASDAQ:ACTG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (3.5), the stock would be worth $0.91 (82% downside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 19.3 | $5.02 |
0%
|
| 3-Year Average | 3.5 | $0.91 |
-82%
|
| 5-Year Average | 3.3 | $0.85 |
-83%
|
| Industry Average | 15.9 | $4.13 |
-18%
|
| Country Average | 19.6 | $5.1 |
+2%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
$213.4m
|
/ |
Jan 2026
$11.1m
|
= |
|
|
$213.4m
|
/ |
Dec 2026
$-51.1m
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Acacia Research Corp
NASDAQ:ACTG
|
484.3m USD | 19.3 | 22.3 | |
| UK |
|
Relx PLC
LSE:REL
|
49.5B GBP | 18.5 | 23.9 | |
| UK |
I
|
IHS Markit Ltd
F:0M3
|
37.9B EUR | 40.2 | 36.5 | |
| CA |
|
Thomson Reuters Corp
TSX:TRI
|
56.8B CAD | 20.9 | 27.1 | |
| IE |
|
Experian PLC
LSE:EXPN
|
26.2B GBP | 19.7 | 25.7 | |
| US |
|
Verisk Analytics Inc
NASDAQ:VRSK
|
24.6B USD | 18.8 | 27.2 | |
| US |
|
Equifax Inc
NYSE:EFX
|
23.6B USD | 24.7 | 35.8 | |
| CH |
|
SGS SA
SIX:SGSN
|
16.9B CHF | 18.9 | 25.8 | |
| US |
|
Leidos Holdings Inc
NYSE:LDOS
|
19.6B USD | 10.9 | 13.5 | |
| NL |
|
Wolters Kluwer NV
AEX:WKL
|
16.1B EUR | 12.8 | 12.3 | |
| US |
U
|
UL Solutions Inc
NYSE:ULS
|
18.4B USD | 0 | 0 |
Market Distribution
| Min | 0 |
| 30th Percentile | 13.6 |
| Median | 19.6 |
| 70th Percentile | 27.8 |
| Max | 1 826 183.2 |
Other Multiples
Acacia Research Corp
Glance View
Acacia Research Corp. engages in the acquisition, development, and patents technologies through its subsidiaries. The company is headquartered in New York City, New York and currently employs 122 full-time employees. The firm's operating subsidiaries partner with inventors and patent owners, applying their legal and technology expertise to patent assets to unlock the financial value in their patented inventions. The firm's operating subsidiaries assist patent owners with the prosecution and development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of their patented technologies and, where necessary, with the enforcement against unauthorized users of their patented technologies through the filing of patent infringement litigation. The firm's operating subsidiaries own or control the rights to multiple patent portfolios, which include the United States patents and certain foreign counterparts, covering technologies used in a range of industries.
